BPC-157 vs CJC-1295: What the Research Shows
BPC-157 and CJC-1295 side by side: what they are, how they are regulated and what is still unknown.
Where the research points
Consider BPC-157 if…
- you want any human reports (a small, uncontrolled report): 14 of 16 patients (87.5%) reported relief with BPC 157 alone or combined with thymosin beta-4 (TB4).[17]
Consider CJC-1295 if…
- you want randomized human hormone data (hormone levels, not a clinical benefit): a single injection raised mean plasma GH 2- to 10-fold for 6 days or more[11]
What they have in common
- Caution on BPC-157 evidence from a systematic review: Only 1 of 36 included studies was clinical; 35 were preclinical.[18]
Spec comparison
Showing 12 of 12 fields where the two differ.
| Field | BPC-157 | CJC-1295 |
|---|---|---|
| Class | Gastric pentadecapeptide | GHRH analog |
| Also called | BPC, body protection compound, Pentadecapeptide BPC 157 | CJC, mod GRF, GRF 1-29 |
| Category | Healing & recovery | Growth hormone |
| FDA status | PCAC voted 8–6 for 503A (Jul 2026) | Not FDA approved · research chemical |
| PCAC vote, Jul 2026 | PCAC voted 8–6 for the 503A list (Jul 2026); not finalized | Not on the Jul 2026 agenda |
| WADA | Prohibited by WADA (S0)BPC-157 is named in S0 (non-approved substances), prohibited at all times, in and out of competition. | Prohibited by WADA (S2.2.4)CJC-1295 is named as a GHRH analogue in S2.2.4 (growth hormone releasing factors), prohibited at all times. |
| Anti-doping detection |
|
|
| Half-life | less than 30 minIV and IM (single and repeated) (rat, beagle dog) · Frontiers in pharmacology 2022, PMID 36588717 | No published half-life foundPubMed search, 11 Oct 2026 |
| Evidence strength | Human observational evidence, 3 of 4Strongest: Alternative therapies in health and medicine 2025, PMID 40131143 | Human RCT evidence, 4 of 4Strongest: The Journal of clinical endocrinology and metabolism 2006, PMID 16352683 |
| Human studies we summarised | 3 human (0 randomized or controlled) of 25 summarised | 4 human (1 randomized or controlled) of 7 summarised |
| Typical study doses |
|
|
| Vial sizes sold | 2 mg, 5 mg, 10 mg, 20 mg | 2 mg, 5 mg, 10 mg |
Bracketed values are pending a sourced figure. Legal data reflects the regulatory events in our tracker.
BPC-157 and CJC-1295 together
People also search for this pair as a stack. The stack page covers timing and interaction questions as they are sourced. Evidence for the combination: No studies tested these together (PubMed search: 7 results, 2 Oct 2026).
Healthy-volunteer hormone studies versus patient symptom reports
CJC-1295's human work is a set of studies in healthy volunteers that track hormone levels. The main report combined two randomized, placebo-controlled, ascending-dose trials in healthy adults.[11]
The same trial found no serious adverse reactions and reported that levels of IGF-I stayed above baseline for up to 28 d after multiple doses.[11]
A separate CJC-1295 study asked whether the natural pulsing of GH survived: after a single injection, pulse frequency and magnitude were unaltered, while baseline (trough) GH rose 7.5-fold.[12]
One human BPC-157 report involved women who underwent cystoscopy and received injections totalling 10 mg of BPC-157 around the area of bladder inflammation during a single procedure.[7]
The systematic review of BPC-157 in sports medicine states that no clinical safety data were found.[18]
Kinetics and how each is used outside trials
CJC-1295 is a synthetic GHRH analog that binds permanently to endogenous albumin after injection, with a half-life of 8 d.[12]
A BPC-157 pharmacokinetic study put absolute bioavailability after intramuscular injection at about 14%-19% in rats and 45%-51% in beagle dogs.[5]
An analysis of internet forum threads on female use of CJC-1295 found people choosing it for weight loss, muscle, skin, sleep and injury healing; the study is about reported behaviour, not outcomes.[21]
Common questions
BPC-157 vs CJC-1295: which is better for injury recovery?
CJC-1295's human trials measured GH and IGF-I levels, not injury healing; the cached CJC-1295 work lists peak concentrations and area under the curve of GH and IGF-I as its main outcomes.[11]
Are BPC-157 and CJC-1295 the same type of peptide?
The cached CJC-1295 paper describes it as a long-acting analog of GH-releasing hormone.[11]
Has CJC-1295 been studied in humans?
Yes, in small trials of healthy adults measuring pharmacokinetics, GH and IGF-I, and no serious adverse reactions were reported in the main dose-escalation trial.[11]
Sources
- 1FDA gives notice that 12 peptides will be removed from Category 2 (nominations withdrawn)FDA · 2026fda.govAccessed 2 Oct 2026
- 2World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
- 3Stable Isotope Labeling-Based Nontargeted Strategy for Characterization of the In Vitro Metabolic Profile of a Novel Doping BPC-157 in Doping Control by UHPLC-HRMS.Molecules (Basel, Switzerland) · 2023PMID 37959764Accessed 2 Oct 2026
- 4Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H.Drug testing and analysis · 2017PMID 28035768Accessed 2 Oct 2026
- 5Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs.Frontiers in pharmacology · 2022PMID 36588717Accessed 2 Oct 2026
- 6Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study.Alternative therapies in health and medicine · 2025PMID 40131143Accessed 2 Oct 2026
- 7Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study.Alternative therapies in health and medicine · 2024PMID 39325560Accessed 2 Oct 2026
- 8Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study.Joint diseases and related surgery · 2026PMID 42542926Accessed 2 Oct 2026
- 9An antibody-free, ultrafiltration-based assay for the detection of growth hormone-releasing hormones in urine at low pg/mL concentrations using nanoLC-HRMS/MS.Journal of pharmaceutical and biomedical analysis · 2022PMID 35298973Accessed 2 Oct 2026
- 10Advances in the detection of growth hormone releasing hormone synthetic analogs.Drug testing and analysis · 2021PMID 34665524Accessed 2 Oct 2026
- 11Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.The Journal of clinical endocrinology and metabolism · 2006PMID 16352683Accessed 2 Oct 2026
- 12Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.The Journal of clinical endocrinology and metabolism · 2006PMID 17018654Accessed 2 Oct 2026
- 13Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse.American journal of physiology. Endocrinology and metabolism · 2006PMID 16822960Accessed 2 Oct 2026
- 14PubMed search: ("CJC-1295"[tiab] OR CJC1295[tiab]) (33 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 15PubMed search: ("CJC-1295"[tiab] OR CJC1295[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (7 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 16PubMed search: ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab] OR "pentadecapeptide BPC"[tiab]) AND ("CJC-1295"[tiab] OR CJC1295[tiab])PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 17Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain.Alternative therapies in health and medicine · 2021PMID 34324435Accessed 2 Oct 2026
- 18Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.HSS journal : the musculoskeletal journal of Hospital for Special Surgery · 2025PMID 40756949Accessed 2 Oct 2026
- 19Advisory committee backs 6 of 7 peptides for the 503A listNCPA · 2026ncpa.org
- 20PubMed search: ("CJC-1295"[tiab] OR CJC1295[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (11 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 21Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions.Substance use & misuse · 2016PMID 26771670Accessed 2 Oct 2026
Found an error? Report a correction.